EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 409 filers reported holding EXELIXIS INC in Q2 2024. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $308,918 | +8.4% | 13,748 | +15.7% | 0.03% | -58.1% |
| Q4 2023 | $285,049 | -26.0% | 11,882 | -32.6% | 0.06% | -6.1% |
| Q3 2023 | $385,216 | -15.9% | 17,630 | -26.5% | 0.07% | -19.5% |
| Q2 2023 | $458,181 | +29.1% | 23,976 | +8.4% | 0.08% | +9.3% |
| Q4 2022 | $354,933 | +0.8% | 22,128 | -1.5% | 0.08% | -13.8% |
| Q3 2022 | $352,000 | +63.0% | 22,467 | +90.0% | 0.09% | -28.7% |
| Q4 2021 | $216,000 | -48.2% | 11,823 | -35.9% | 0.12% | -39.9% |
| Q1 2021 | $417,000 | – | 18,441 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |